Share Twitter LinkedIn Facebook Email Andre Goy, MD, Chairman and Director of the John Theurer Cancer Center (JTCC) at Hackensack University Medical Center and Chief of the Division of Lymphomas shares the exciting new data in lymphoma involving novel therapy for patients.
2024 Update on Lymphoma Treatment: Navigating the Latest Advances – Elizabeth Brem, MD [38 Slides] Hodgkin Lymphoma 4 Mins Read
FDA Grants Accelerated Approval to Zanubrutinib (Brukinsa) for Relapsed or Refractory Follicular Lymphoma Lymphoma 2 Mins Read
FDA Grants Priority Review of Epcoritamab (EPKINLY): A Significant Step in Lymphoma Treatment [VIDEO EXCLUSIVE] Lymphoma 3 Mins Read